Authors Katty Kay and Claire Shipman look at research showing women lack self-assurance in their careers – and just as important examine what to do about it.

Hosted on Acast. See acast.com/privacy for more information.

The words phrases and yes even the emoticons we use on social media tell a lot about our personalities and collectively give a detailed picture of overall well-being.

Hosted on Acast. See acast.com/privacy for more information.

Companies both in and outside the entertainment industry can learn numerous lessons from the recent Sony hacking about the importance of beefing up IT security.

Hosted on Acast. See acast.com/privacy for more information.

Learning from the cuts to retiree benefits in some pension plans that Congress allowed last weekend today’s workers must work longer and save more says Wharton’s Olivia S. Mitchell.

Hosted on Acast. See acast.com/privacy for more information.

The Apple antitrust case involving iPod users brings up questions about whether the tech giant was being anticompetitive or simply trying to improve its product.

Hosted on Acast. See acast.com/privacy for more information.

After the demise of its Nook partnership with Microsoft Barnes & Noble should look to Starbucks for what to do next Wharton experts say.

Hosted on Acast. See acast.com/privacy for more information.

Nunzio Quacquarelli founder of higher education solutions firm QS discusses the innovations that will shape the sector’s future and how his company can play a role.

Hosted on Acast. See acast.com/privacy for more information.

Thanks to plummeting costs and state support America’s energy sector could go mostly green within a decade says CEO of the Coalition for Green Capital and ex-FCC chairman Reed Hundt.

Hosted on Acast. See acast.com/privacy for more information.

Amazon’s recent move to advertise product-related local services faces obstacles in trust credibility and competition from informal local networks say experts.

Hosted on Acast. See acast.com/privacy for more information.

A windfall for the Cystic Fibrosis Foundation from a wonder drug may bring new investments to pharmaceutical development but such deals also come with risks.

Hosted on Acast. See acast.com/privacy for more information.